1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-(1-piperidyl)but-2-en-1-one

ID: ALA4642158

PubChem CID: 78322297

Max Phase: Preclinical

Molecular Formula: C32H31ClFN5O3

Molecular Weight: 588.08

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(/C=C/CN1CCCCC1)N1CCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21

Standard InChI:  InChI=1S/C32H31ClFN5O3/c33-26-17-24(9-10-29(26)42-20-22-6-4-7-23(34)16-22)37-32-25-18-28-30(19-27(25)35-21-36-32)41-15-14-39(28)31(40)8-5-13-38-11-2-1-3-12-38/h4-10,16-19,21H,1-3,11-15,20H2,(H,35,36,37)/b8-5+

Standard InChI Key:  DNUQLUIXZOFJFJ-VMPITWQZSA-N

Molfile:  

 
     RDKit          2D

 42 47  0  0  0  0  0  0  0  0999 V2000
   22.2829  -15.7412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2829  -16.5626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9923  -16.9670    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.9923  -15.3244    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.7017  -15.7412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7001  -16.5608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4043  -16.9680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4035  -15.3307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1124  -15.7385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1116  -16.5607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8228  -16.9687    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.5352  -16.5597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5320  -15.7343    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.8203  -15.3259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8175  -14.5045    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.5279  -14.0935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2404  -14.5050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9504  -14.0947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9480  -13.2725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2298  -12.8624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5228  -13.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6634  -14.5012    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   28.6579  -12.8564    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.3717  -13.2658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0774  -12.8497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7882  -13.2632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4976  -12.8478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4942  -12.0256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7754  -11.6206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0689  -12.0342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2112  -13.2575    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   22.9923  -14.5031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7041  -14.0945    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.2805  -14.0945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5686  -14.5031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8568  -14.0945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1450  -14.5031    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.4294  -14.0901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7238  -14.4952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7196  -15.3168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4271  -15.7317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1430  -15.3209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  5  6  2  0
  6  7  1  0
  7 10  2  0
  9  8  2  0
  8  5  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 18 22  1  0
 19 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 27 31  1  0
  4 32  1  0
 32 33  2  0
 32 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 37 42  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
M  END

Associated Targets(Human)

NCI-N87 (850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1975 (4994 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-431 (6446 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BT-474 (2113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Calu-3 (339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 588.08Molecular Weight (Monoisotopic): 587.2099AlogP: 6.51#Rotatable Bonds: 8
Polar Surface Area: 79.82Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.42CX LogP: 5.97CX LogD: 4.91
Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.24Np Likeness Score: -1.47

References

1. Sun M, Jia J, Sun H, Wang F..  (2020)  Design and synthesis of a novel class EGFR/HER2 dual inhibitors containing tricyclic oxazine fused quinazolines scaffold.,  30  (9): [PMID:32139324] [10.1016/j.bmcl.2020.127045]

Source